Home › NCT06121466

Effect of Abdominal Wall Injections on Abdominal Pain

Who can join

Ages 18 to 100 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Localized abdominal wall pain
* Average daily pain (7-day recall) ≥ 3 on a scale of 0-10
* Suspected abdominal wall etiology for abdominal pain
* Positive Carnett's sign or pain near an incisional site
* 18 years of age or older

Exclusion Criteria:

* Suspected visceral etiology for the abdominal pain
* Severe allergy to lidocaine
* Unwillingness or inability to provide informed consent
* Low probability of follow-up
* Abdominal wall hernia noted at the point of pain
* History of trigger point injections for abdominal pain
* Bleeding disorder
* Pregnancy, incarceration or decisionally impaired

About the study

This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.

What is being tested

• Abdominal wall injections with lidocaine 2% (drug)

Sponsor: Oregon Health and Science University · Participants: 45 · Started: Jan 1, 2023

Contact the study team

• Sophia Lichenstein-Hill, DNP · Phone: 5038801235

Official record on ClinicalTrials.gov — NCT06121466

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.